Nektar.Ai

Nektar.Ai company information, Employees & Contact Information

Explore related pages

Related company profiles:

World's first RevOps AI Agent that: 1. Captures & Unifies customer interaction journey scattered across your frontline teams & GTM tools. 2. Automatically plugs your CRM's existing sales process data gaps at scale. 3. Discovers hidden Revenue Insights across your customer relationships and business conversations. 4. Tracks time spent & resource utilization of GTM teams like presales, solution engineering & customer support & recommends optimization opportunities to drive productivity and opportunity coverage. All this with: - Zero Adoption hassle, - Go live in under a week, - Value is delivered upfront on the day of Go-live itself. AI Pitchfield finalist-2025, an event organized by Salesforce. #1 Product of the Day on Product Hunt; 4.7 rating on G2. Trusted by dozens of Enterprise customers like Alteryx, Mimecast, Docusign, Crunchbase, Signifyd, EDB & more to drive Revenue Efficiency using AI.
Looking for a particular Nektar.Ai employee's phone or email?

Nektar.ai Questions

News

Will Nektar Therapeutics stock benefit from AI adoption - Market Trend Report & Safe Capital Growth Tips - newser.com

Will Nektar Therapeutics stock benefit from AI adoption - Market Trend Report & Safe Capital Growth Tips newser.com

Nektar Therapeutics Data from REZOLVE-AD Study Accepted for Late-Breaking Oral Presentation - Insider Monkey

Nektar Therapeutics Data from REZOLVE-AD Study Accepted for Late-Breaking Oral Presentation Insider Monkey

Will Nektar Therapeutics stock benefit from AI adoption - Long Setup & Accurate Technical Buy Alerts - newser.com

Will Nektar Therapeutics stock benefit from AI adoption - Long Setup & Accurate Technical Buy Alerts newser.com

A Look at Nektar Therapeutics's Valuation Following FDA Fast Track Win for Lead Eczema Drug - simplywall.st

A Look at Nektar Therapeutics's Valuation Following FDA Fast Track Win for Lead Eczema Drug simplywall.st

Why Nektar Therapeutics stock is a must watch in 2025 - July 2025 Volume & AI Driven Stock Price Forecasts - Trung tâm Dự báo KTTV quốc gia

Why Nektar Therapeutics stock is a must watch in 2025 - July 2025 Volume & AI Driven Stock Price Forecasts Trung tâm Dự báo KTTV quốc gia

Nektar Announces REZOLVE-AD Phase 2b Results for Rezpegaldesleukin Selected for Late-Breaker Oral Presentation at EADV 2025 - Yahoo Finance

Nektar Announces REZOLVE-AD Phase 2b Results for Rezpegaldesleukin Selected for Late-Breaker Oral Presentation at EADV 2025 Yahoo Finance

Nektar Therapeutics Stock Doubles After Promising Eczema Drug Trial Results - Investopedia

Nektar Therapeutics Stock Doubles After Promising Eczema Drug Trial Results Investopedia

Will Nektar Therapeutics stock benefit from AI adoption - 2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com

Will Nektar Therapeutics stock benefit from AI adoption - 2025 Top Gainers & Risk Controlled Daily Trade Plans newser.com

Tech companies are taking over this S.F. neighborhood as OpenAI closes in on new space - San Francisco Chronicle

Tech companies are taking over this S.F. neighborhood as OpenAI closes in on new space San Francisco Chronicle

Why Nektar Therapeutics Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket - Benzinga

Why Nektar Therapeutics Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket Benzinga

Nektar Nails Phase 2b Eczema Trial: BTIG Calls It A ‘Pound the Table BUY’, Wainwright Sees $120 Upside - Stocktwits

Nektar Nails Phase 2b Eczema Trial: BTIG Calls It A ‘Pound the Table BUY’, Wainwright Sees $120 Upside Stocktwits

Nektar Control Surface For Steinberg Software - Sonicstate

Nektar Control Surface For Steinberg Software Sonicstate

Nektar Therapeutics CEO sells $430k in stock - Investing.com India

Nektar Therapeutics CEO sells $430k in stock Investing.com India

Singapore-based Nektar.ai gets $6M to help B2B sales team collaborate more effectively - TechCrunch

Singapore-based Nektar.ai gets $6M to help B2B sales team collaborate more effectively TechCrunch

Nektar Therapeutics (NKTR) Announced Positive results for Rezpegaldesleukin - Yahoo Finance

Nektar Therapeutics (NKTR) Announced Positive results for Rezpegaldesleukin Yahoo Finance

Will Nektar Therapeutics stock benefit from AI adoption - Weekly Gains Report & Reliable Intraday Trade Plans - newser.com

Will Nektar Therapeutics stock benefit from AI adoption - Weekly Gains Report & Reliable Intraday Trade Plans newser.com

Nektar.ai closes a seed round of US$8.1 million as it aims to enable data-driven smart work for B2B SaaS revenue teams - PR Newswire

Nektar.ai closes a seed round of US$8.1 million as it aims to enable data-driven smart work for B2B SaaS revenue teams PR Newswire

Biolojic Design Announces that Nektar Therapeutics Has Exercised Its License Option to Develop an AI-Designed Agonistic Antibody Targeting TNFR2 for the Treatment of Autoimmune Diseases - GlobeNewswire

Biolojic Design Announces that Nektar Therapeutics Has Exercised Its License Option to Develop an AI-Designed Agonistic Antibody Targeting TNFR2 for the Treatment of Autoimmune Diseases GlobeNewswire

Nektar Therapeutics (NASDAQ:NKTR) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance

Nektar Therapeutics (NASDAQ:NKTR) Analysts Are Cutting Their Estimates: Here's What You Need To Know Yahoo Finance

Nektar Therapeutics (NKTR): Among Stocks Wall Street Is Calling Bullish Amid Market Turmoil - Yahoo Finance

Nektar Therapeutics (NKTR): Among Stocks Wall Street Is Calling Bullish Amid Market Turmoil Yahoo Finance

Why Nektar Therapeutics Rippled Higher This Week - Yahoo Finance

Why Nektar Therapeutics Rippled Higher This Week Yahoo Finance

Nektar Therapeutics Data from REZOLVE-AD Study Accepted for Late-Breaking Oral Presentation - Yahoo Finance

Nektar Therapeutics Data from REZOLVE-AD Study Accepted for Late-Breaking Oral Presentation Yahoo Finance

Will Nektar Therapeutics (ITH0) stock outperform foreign stocks - Quarterly Market Summary & High Yield Stock Recommendations - Trung tâm Dự báo KTTV quốc gia

Will Nektar Therapeutics (ITH0) stock outperform foreign stocks - Quarterly Market Summary & High Yield Stock Recommendations Trung tâm Dự báo KTTV quốc gia

FDA grants fast track designation to Nektar’s rezpegaldesleukin in alopecia areata - PMLiVE

FDA grants fast track designation to Nektar’s rezpegaldesleukin in alopecia areata PMLiVE

Nektar Therapeutics stock jumps after Sanofi’s amlitelimab data disappoints - Investing.com

Nektar Therapeutics stock jumps after Sanofi’s amlitelimab data disappoints Investing.com

Piper Sandler reiterates Overweight rating on Nektar Therapeutics stock - Investing.com

Piper Sandler reiterates Overweight rating on Nektar Therapeutics stock Investing.com

Why Nektar Therapeutics (NKTR) Is Among the Best Penny Stocks to Invest In According to Media? - Yahoo Finance

Why Nektar Therapeutics (NKTR) Is Among the Best Penny Stocks to Invest In According to Media? Yahoo Finance

FDA Fast-Tracks Revolutionary Alopecia Drug as Nektar Targets December Data Release - Stock Titan

FDA Fast-Tracks Revolutionary Alopecia Drug as Nektar Targets December Data Release Stock Titan

Nektar Therapeutics Announces Public Offering of Shares - TipRanks

Nektar Therapeutics Announces Public Offering of Shares TipRanks

Nektar Therapeutics Reveals Promising Phase 2b Study Results - TipRanks

Nektar Therapeutics Reveals Promising Phase 2b Study Results TipRanks

Should You Embrace Positive Friction in Your CX Design? - CMSWire

Should You Embrace Positive Friction in Your CX Design? CMSWire

Merck KGaA taps AI-focused biotech for new ADC pact worth $376M - Fierce Biotech

Merck KGaA taps AI-focused biotech for new ADC pact worth $376M Fierce Biotech

Nektar Therapeutics Approves Reverse Stock Split - TipRanks

Nektar Therapeutics Approves Reverse Stock Split TipRanks

Nektar Therapeutics Elects New Board, Approves Key Proposals - TipRanks

Nektar Therapeutics Elects New Board, Approves Key Proposals TipRanks

Why Nektar Therapeutics stock is a must watch in 2025 - 2025 Macro Impact & Advanced Swing Trade Entry Alerts - Trung tâm Dự báo KTTV quốc gia

Why Nektar Therapeutics stock is a must watch in 2025 - 2025 Macro Impact & Advanced Swing Trade Entry Alerts Trung tâm Dự báo KTTV quốc gia

Nektar Therapeutics Announces Positive Phase 2b Trial Results - TipRanks

Nektar Therapeutics Announces Positive Phase 2b Trial Results TipRanks

Nektar Therapeutics Shares Double On Promising Eczema Drug Data - Benzinga

Nektar Therapeutics Shares Double On Promising Eczema Drug Data Benzinga

Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September - The Globe and Mail

Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September The Globe and Mail

Forethought bolsters AI platform team amid growing market demand - Mi-3.com.au

Forethought bolsters AI platform team amid growing market demand Mi-3.com.au

Why Nektar Therapeutics Stock Was Red-Hot Today - The Globe and Mail

Why Nektar Therapeutics Stock Was Red-Hot Today The Globe and Mail

Nektar.ai raises $6 Mn in seed round - Entrackr

Nektar.ai raises $6 Mn in seed round Entrackr

Nektar Therapeutics (NKTR) Stock: Soars Over 120% as Eczema Drug Shows Breakthrough Results in Mid Stage Trial - CoinCentral

Nektar Therapeutics (NKTR) Stock: Soars Over 120% as Eczema Drug Shows Breakthrough Results in Mid Stage Trial CoinCentral

Nektar Sues Eli Lilly for Incorrect Clinical Trial Results - TechTarget

Nektar Sues Eli Lilly for Incorrect Clinical Trial Results TechTarget

Forethought Boosts BrandComms.AI Platform With New Hires & Promotions - bandt.com.au

Forethought Boosts BrandComms.AI Platform With New Hires & Promotions bandt.com.au

2023's top 10 clinical trial flops - Fierce Biotech

2023's top 10 clinical trial flops Fierce Biotech

Meet The Startups Carving India’s Niche In The AI Space - Inc42

Meet The Startups Carving India’s Niche In The AI Space Inc42

Nektar Asset Management to Shut Down Long-Running Hedge Fund - Institutional Investor

Nektar Asset Management to Shut Down Long-Running Hedge Fund Institutional Investor

Nektar announces closure of Sweden's pioneering hedge fund - AMWatch

Nektar announces closure of Sweden's pioneering hedge fund AMWatch

Top Nektar.Ai Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant